Fact Check: Pharmaceutical research and development is essential for new drug discovery.

Fact Check: Pharmaceutical research and development is essential for new drug discovery.

Published July 3, 2025
VERDICT
True

# Fact Check: "Pharmaceutical research and development is essential for new drug discovery." ## What We Know Pharmaceutical research and development ...

Fact Check: "Pharmaceutical research and development is essential for new drug discovery."

What We Know

Pharmaceutical research and development (R&D) plays a critical role in the discovery of new drugs. The process of drug discovery is complex and lengthy, often taking over 12 years and costing approximately $2.6 billion to develop a new molecular entity (NME) or new biological entity (NBE) (source-1). This process begins with identifying biological targets that are implicated in diseases, which is foundational for developing new treatments (source-1).

The U.S. Food and Drug Administration (FDA) outlines that drug discovery typically involves new insights into disease processes, extensive testing of molecular compounds, and the application of new technologies to identify potential drug candidates (source-3). This highlights the necessity of ongoing research to facilitate the identification and development of effective medications.

Analysis

The claim that pharmaceutical research and development is essential for new drug discovery is supported by multiple credible sources. For instance, the article from the National Institutes of Health emphasizes that the drug development process is not only long and expensive but also fraught with uncertainties and failures. It notes that many biological targets must be explored to yield a single approved medicine, illustrating the intricate nature of drug discovery (source-1).

Moreover, the FDA's description of the drug development process corroborates the claim by detailing how researchers utilize insights from ongoing research to design new drugs. This includes understanding how drugs interact with biological systems and determining their safety and efficacy (source-3).

While some may argue that existing drugs can be repurposed or improved without extensive R&D, the evidence overwhelmingly supports the notion that new drug discovery fundamentally relies on innovative research efforts to identify and validate new therapeutic targets (source-2).

The reliability of these sources is high, as they come from established institutions and peer-reviewed articles. The FDA is a regulatory authority with a vested interest in ensuring drug safety and efficacy, while the NIH is a leading biomedical research agency.

Conclusion

The verdict is True. Pharmaceutical research and development is indeed essential for new drug discovery. The intricate processes involved in identifying biological targets, conducting extensive testing, and developing new compounds underscore the necessity of ongoing research in the pharmaceutical industry. Without such R&D efforts, the discovery of new and effective medications would be significantly hindered.

Sources

  1. Drug discovery and development: Role of basic biological research
  2. Editorial: Innovative approaches in drug discovery and development
  3. Step 1: Discovery and Development | FDA
  4. The Importance of Pharmaceutical Research in The Process of Creating New Drugs
  5. The Research and Development Pipeline: A Primer
  6. The Drug Development Process: A Closer Look at Its Meaning and Its Phases

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: Pharmaceutical research and development is essential for medical advancements.
True
🎯 Similar

Fact Check: Pharmaceutical research and development is essential for medical advancements.

Detailed fact-check analysis of: Pharmaceutical research and development is essential for medical advancements.

Jul 3, 2025
Read more →
Fact Check: Pharmaceutical research and development is crucial for medical advancements.
True
🎯 Similar

Fact Check: Pharmaceutical research and development is crucial for medical advancements.

Detailed fact-check analysis of: Pharmaceutical research and development is crucial for medical advancements.

Jul 3, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Pharmaceutical research and development is a significant part of healthcare costs.
Unverified

Fact Check: Pharmaceutical research and development is a significant part of healthcare costs.

Detailed fact-check analysis of: Pharmaceutical research and development is a significant part of healthcare costs.

Jul 3, 2025
Read more →
Fact Check: Pharmaceutical companies conduct studies to seek drug approvals.
True

Fact Check: Pharmaceutical companies conduct studies to seek drug approvals.

Detailed fact-check analysis of: Pharmaceutical companies conduct studies to seek drug approvals.

Jul 3, 2025
Read more →